Title: The potential of cannabidiol (CBD) as a treatment for anxiety disorders

Krizan Novale

Anxiety disorders affect a significant portion of the population and can significantly impair quality of life. While there are several pharmacological treatments available, many individuals do not respond well to traditional medications or experience unwanted side effects. Recently, there has been increasing interest in the potential of cannabidiol (CBD), a non-psychoactive component of the Cannabis sativa plant, as a treatment for anxiety disorders. Preclinical studies have demonstrated that CBD has anxiolytic effects and may modulate the activity of serotonin receptors in the brain, which are important targets for traditional antidepressant and anxiolytic medications. In addition, CBD has been shown to have a favorable safety profile in humans, with few adverse effects reported in clinical trials